RPA1 and B-cell chronic lymphocytic leukemia: Although treatment with bendamustine alone led to minimal DNA damage in the CLL cells cultured on the CD40L-expressing stroma, both single- and double-strand DNA damage was enhanced in the presence of both drugs, evidenced by phosphorylation of RPA, H2AX and p-NBS1 (Figure 6c).